MyDrHank Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.4/10
Best for: an oral route if you will not self-inject
MyDrHank falls below our bar on disclosure. It charges from $171 a month, paid up front; its compounded semaglutide, at $249, is 25% above the $199 median among the sellers we compare.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
charged as a multi-month plan up front
Covered by the monthly price
Medication
Not stated
Clinician visits
Not stated
Shipping
Not stated
Lab work
Not stated
Coaching
Not stated
Prices checked October 2026
MyDrHank is a telehealth brand run by Dr. Hank, LLC that sells compounded semaglutide two ways, weekly shots or a daily tablet compounded with anti-nausea ondansetron, plus compounded tirzepatide. ED, hair and peptide lines sit beside it. Month to month, oral semaglutide is $249, injectable semaglutide $259 and tirzepatide $349; the yearly plan, paid up front, brings those to $171, $178 and $240 a month.
Is MyDrHank legit?
Yes. MyDrHank is a real, operating US company, and we found no FDA warning letters issued to it. We rate it 6.4/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there a MyDrHank promo or coupon code?
We know of no promo or coupon code for MyDrHank. Its listed price is $25 a month. Coupon sites advertising "MyDrHank discount codes" are not a source we can vouch for, and any genuine offer shows at checkout without a code.
See how MyDrHank compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
MyDrHank at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $171/mo
- FDA status
- No FDA warning letters found
How MyDrHank scores
Six columns, each one computed from something MyDrHank has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
3.4/10$249/month is 25% above the $199 median for compounded semaglutide across the sellers we compare. A cheaper plan paid several months up front is also listed.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10A price is shown before the questionnaire starts.
Trust & Safety15%
5.5/10No pharmacy is named for its prescriptions. It shows a price before asking for health information.
Accessibility10%
5.0/10No state list is available to check, so this is held at the midpoint rather than scored on reach.
Support10%
5.0/10States too little about what the monthly cost covers to score the bundle. Held at the midpoint rather than assumed.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on MyDrHank
Last checked October 2026- Checked the listed price across 14 dose or plan tiers
- Checked FDA warning letters for MyDrHank
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with MyDrHank involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1MyDrHank shows a price on its own site before asking anything about you, so you can compare it with other sellers before you start a questionnaire.
- 2Ask MyDrHank which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- Lowest ongoing monthly price: semaglutide $171, tirzepatide $240. That leaves out membership fees, first-month rates and insurance copays.
- Confirm that MyDrHank serves your state before you start.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Contacting MyDrHank
- Phone
- (888) 588-8094
- MyDrHank offers email support
Medications MyDrHank lists
MyDrHank lists compounded semaglutide and compounded tirzepatide. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.
Pricing
Prices re-verified
Plans: 6 months for $150 total ($25/mo), 3 months for $90 ($30/mo), 1 month for $35. The tablet strength in mg is not shown before purchase.
Unchanged.
Unchanged. Tiers: 6-Month $180/$30; 3-Month $105/$35; 1-Month $45.
Unchanged.
Unchanged. Tiers: 6-Month $210/$35; 3-Month $120/$40; 1-Month $49.
Unchanged.
Unchanged. Tiers: 6-Month $270/$45; 3-Month $150/$50; 1-Month $59.
Unchanged.
Monthly $249; quarterly $635 ($212/mo); 6-month $1,143 ($190/mo); yearly $2,057 ($171/mo). Product pages now show only 'From $171/mo', the yearly average. A 'Tablets' variant carries different figures: monthly total $399 shown as $329/mo, yearly $3,297 ($275/mo).
This yearly average is the 'From $171/mo' figure on the product page.
Tiers: Monthly $259; Quarterly $660/$220; 6-Month $1,189/$198; Yearly $2,140/$178. Above the $175 sema median unless a long commitment is taken.
Monthly $349; quarterly $890 ($297/mo); 6-month $1,602 ($267/mo); yearly $2,883 ($240/mo). The site's disclaimer says tirzepatide plans start at $200/mo; no $200 tier exists.
Check the price yourself before you pay
Every figure here comes from MyDrHank's own website, as of the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- We found no FDA warning letters issued to MyDrHank
Against it
- Semaglutide costs $249 a month, 25% above the $199 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $349 a month, 30% above the $269 median for compounded tirzepatide across the sellers we compare
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What MyDrHank charges
The standing price at MyDrHank is $171/month.
- Compounded sildenafil (1-month plan): $35/month
- Compounded sildenafil (6-month plan): $25/month
- Compounded tadalafil (1-month plan): $45/month
- Compounded tadalafil (6-month plan): $30/month
- Compounded tadalafil (low-dose daily; 1-month plan): $49/month
- Compounded semaglutide (tablet, 12-month plan): $171/month
For compounded semaglutide, the median across the sellers we compare is $199/month, so MyDrHank's $249 is a premium, and a premium has to buy something. Check what is bundled before you accept it. Some of MyDrHank's plans are paid several months up front, so read the terms you agree to at checkout before you choose a longer one. For scale, the dearest tenth of compounded sellers charges about three times the cheapest tenth.
MEDGm dispenses semaglutide and tirzepatide from $169/month, which makes it the fair comparison to run before you commit here.
What MyDrHank dispenses
MyDrHank prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two best-evidenced weight-loss molecules currently on the market. These are compounded preparations from a licensed pharmacy rather than approved pens, which is where the lower price comes from. A compounded drug is not FDA-approved as a finished product: the specific preparation has not been reviewed for safety, efficacy or manufacturing quality. For what differs besides the price, see compounded semaglutide vs Ozempic and Wegovy.
Safety and disclosure
MyDrHank tells you its price before you start the medical questionnaire. We found no FDA warning letters issued to MyDrHank. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If MyDrHank will not tell you, treat that as a warning sign. Once you have the pharmacy's name, 503A vs 503B explains which regulator oversees it and how to check. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You care most about the twelve-month total, not the first bill. A flat-rate seller such as Collective will usually win that math.
- You want the FDA-approved pen specifically. Everything listed here is compounded.
- You need insurance to cover the cost. Check whether MyDrHank bills your plan before you start.
Our read
MyDrHank costs more than the middle of this market. If the extras it charges for are ones you would actually use, that is a defensible trade. If not, the same molecule is available for less. The catch is disclosure, which is why MyDrHank scores low on Trust & Safety: settle the pharmacy and pricing questions above before the price decides for you.
The Bottom Line
MyDrHank falls below our bar on disclosure. It charges from $171 a month, paid up front; its compounded semaglutide, at $249, is 25% above the $199 median among the sellers we compare.
Before you pay MyDrHank
Starting at $171 a month. Check today's price, then start the intake.
Where MyDrHank is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these three counts, another seller does better.
- If you need the FDA-approved pen rather than a compounded vial, consider WellMedRx.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo + membership).
- If you want a human checking in, not just a prescription, consider Eden.
If none of these fits, our guide to alternatives to MyDrHank sets more sellers in the same category beside MyDrHank on price, states and what the price includes.
Alternatives to MyDrHank
Collective
Best for: flat any-dose pricing, if you can absorb a $199 annual membership on top
Editorial score · methodology
Embody
Best for: a flat compounded tirzepatide or semaglutide price at every dose, from a seller that names its pharmacies
Editorial score · methodology
Luvo Health
Best for: moving between compounded and brand without changing seller
Editorial score · methodology
Compare MyDrHank head to head
Our head-to-head pages for MyDrHank are MyDrHank vs Gala, MyDrHank vs Direct Meds, MyDrHank vs Embody, MyDrHank vs CoreAge Rx, and MyDrHank vs SkinnyRx.
Frequently Asked Questions
How to check MyDrHank yourself
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this MyDrHank review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of October 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
See MyDrHank's current pricing
Plans start at $171 a month. Whether you qualify is a clinician's decision, made after your intake.